Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1622.30
10.30 (0.64%)
< Home < Back

Sun Pharmaceutical Industries, Ranbaxy sign pact with 2 plaintiff groups to settle claims

Date: 24-03-2022

Sun Pharmaceutical Industries along with its US-based arm Ranbaxy, Inc, has signed a $ 485 million settlement with two plaintiff groups regarding Ranbaxy generic drug application antitrust litigation. The case has been ongoing in the U.S. District Court for the District of Massachusetts (USA) for several years.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.